Canagliflozin vs Gefitinib

Canagliflozin vs Gefitinib: Overview

This comparison examines the pharmacological differences between Canagliflozin and Gefitinib.

Mechanism of Action

Canagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Pharmacokinetics

Half-life: Canagliflozin — 10.6 hours; Gefitinib — 48 hours.

Chemical Properties

Molecular Formula: Canagliflozin — C24H25FO5S; Gefitinib — C22H24ClFN4O3.

Molecular Weight: Canagliflozin — 444.5170 g/mol; Gefitinib — 446.9000 g/mol.

Type: Canagliflozin — Small molecule; Gefitinib — Small molecule.